4//SEC Filing
Ozeroff Christopher David 4
Accession 0001209191-21-069964
CIK 0000907654other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:33 PM ET
Size
6.7 KB
Accession
0001209191-21-069964
Insider Transaction Report
Form 4
Ozeroff Christopher David
EVP & General Counsel
Transactions
- Award
Stock Option (right to buy)
2021-12-14+27,500→ 27,500 totalExercise: $2.29Exp: 2031-12-14→ Common Stock (27,500 underlying)
Holdings
- 50,970
Common Stock
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan (the Plan), vesting in 36 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeother
Related Parties
1- filerCIK 0001454996
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:33 PM ET
- Size
- 6.7 KB